{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:09:13Z","timestamp":1788865753192,"version":"build-2803163510"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Henan Province Young and Middle-aged Health Science and Technology Innovation Leading Talent Training Program","award":["YXKC2022008"],"award-info":[{"award-number":["YXKC2022008"]}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["252300421374"],"award-info":[{"award-number":["252300421374"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82570171"],"award-info":[{"award-number":["82570171"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC2510500"],"award-info":[{"award-number":["2024YFC2510500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Venous thromboembolism (VTE) is a common complication in patients with lung cancer and remains difficult to predict accurately using existing risk assessment tools. This study aimed to develop and validate a machine learning model for individualized prediction of VTE risk in patients with lung cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 7,959 patients with lung cancer from the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital were included, among whom 1,333 developed VTE. Patients were randomly assigned to the training and testing cohorts in a 7:3 ratio. Candidate predictors were identified from 67 clinical variables using multivariable logistic regression and least absolute shrinkage and selection operator (LASSO) regression. Seven prediction models were developed based on the selected variables, including logistic regression, Decision Tree, Random Forest, Extreme Gradient Boosting, Light Gradient Boosting Machine, Support Vector Machine, and Artificial Neural Network (ANN). Model performance was evaluated using the area under the receiver operating characteristic curve, F1 score, calibration curves, and decision curve analysis, and SHapley Additive exPlanation was used to interpret feature contributions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twelve variables were selected for model construction: sex, age, anticoagulant use, atherosclerosis, chemotherapy, intermittent pneumatic compression, radiotherapy, CYFRA21-1, NSE, central venous catheter placement, thrombin time, and D-dimer. Among the seven models, ANN showed the best overall performance, with the highest mean cross-validated area under the receiver operating characteristic curve in the training cohort (0.825\u202f\u00b1\u202f0.016), a testing-cohort value of 0.817 (95% CI 0.794\u20130.840), and the highest F1 score. Calibration analysis showed good agreement between predicted and observed probabilities, and decision curve analysis supported the potential clinical utility of the model across relevant threshold probabilities. SHapley Additive exPlanation further illustrated the contribution and relative importance of each predictor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>An interpretable ANN model was developed for individualized prediction of VTE risk in patients with lung cancer. The model incorporates 12 routinely available clinical variables and may support identification of patients at high risk of VTE, risk stratification, and clinical decision-making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1853920","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:54:57Z","timestamp":1783490097000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of an interpretable machine learning model for venous thromboembolism risk prediction in patients with lung cancer: a real-world study"],"prefix":"10.3389","volume":"13","author":[{"given":"Ao","family":"Xia","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanjuan","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Hemostasis and Thrombosis Diagnostic Engineering Research Center of Henan Province","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Hematology, Huaihe Hospital of Henan University","place":["Kaifeng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjie","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Hemostasis and Thrombosis Diagnostic Engineering Research Center of Henan Province","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Hemostasis and Thrombosis Diagnostic Engineering Research Center of Henan Province","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiance","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Follow-up Center, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqun","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Hemostasis and Thrombosis Diagnostic Engineering Research Center of Henan Province","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1182\/blood.2020007338","article-title":"Venous thromboembolism in cancer patients: a population-based cohort study","volume":"137","author":"Mulder","year":"2021","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy","volume":"5","author":"Khorana","year":"2007","journal-title":"J Thromb Haemost"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/jth.15250","article-title":"Pulmonary embolism at autopsy in cancer patients","volume":"19","author":"Gimbel","year":"2021","journal-title":"J Thromb Haemost"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"100739","DOI":"10.1016\/j.lanepe.2023.100739","article-title":"Impact of venous thromboembolism on the mortality in patients with cancer: a population-based cohort study","volume":"34","author":"S\u00f8rensen","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1182\/bloodadvances.2022009577","article-title":"Survival after cancer-related venous thrombosis: the Scandinavian thrombosis and Cancer study","volume":"7","author":"Crobach","year":"2023","journal-title":"Blood Adv"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-022-00336-y","article-title":"Cancer-associated venous thromboembolism","volume":"8","author":"Khorana","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2147\/CEOR.S39964","article-title":"Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States","volume":"5","author":"Khorana","year":"2013","journal-title":"Clinicoecon Outc. Res"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","article-title":"Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis","volume":"100","author":"Prandoni","year":"2002","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1634\/theoncologist.2016-0414","article-title":"A predictive score for thrombosis associated with breast, colorectal, lung, or ovarian cancer: the prospective COMPASS-Cancer-associated thrombosis study","volume":"22","author":"Gerotziafas","year":"2017","journal-title":"Oncologist"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1182\/bloodadvances.2021006484","article-title":"Validation of the Khorana score for predicting venous thromboembolism in 40,218 patients with cancer initiating chemotherapy","volume":"6","author":"Overvad","year":"2022","journal-title":"Blood Adv"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e77339","DOI":"10.2196\/77339","article-title":"Machine learning in the prediction of venous thromboembolism: systematic review and meta-analysis","volume":"27","author":"Ma","year":"2025","journal-title":"J Med Internet Res"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"103330","DOI":"10.1016\/j.eclinm.2025.103330","article-title":"Nutritional management adherence via an ePRO platform in patients with cancer: a machine learning model study","volume":"85","author":"Xie","year":"2025","journal-title":"EClinicalMedicine"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12933-025-02615-w","article-title":"Predicting major adverse cardiac events in diabetes and chronic kidney disease: a machine learning study from the Silesia diabetes-heart project","volume":"24","author":"Kwiendacz","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"103661","DOI":"10.1016\/j.eclinm.2025.103661","article-title":"Liver regeneration-associated machine learning architecture integrating time-phased predictions for post-hepatectomy liver failure","volume":"90","author":"Shen","year":"2025","journal-title":"EClinicalMedicine"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"103401","DOI":"10.1016\/j.eclinm.2025.103401","article-title":"Development and validation of an interpretable machine learning model for retrospective identification of suspected infection for sepsis surveillance: a multicentre cohort study","volume":"87","author":"Tuinte","year":"2025","journal-title":"EClinicalMedicine"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"103502","DOI":"10.1016\/j.artint.2021.103502","article-title":"Explaining individual predictions when features are dependent: more accurate approximations to Shapley values","volume":"298","author":"Aas","year":"2021","journal-title":"Artif Intell"},{"key":"ref18","first-page":"304","article-title":"Clinical assessment of venous thromboembolic risk in surgical patients","volume":"17","author":"Caprini","year":"1991","journal-title":"Semin Thromb Hemost"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1111\/j.1538-7836.2010.04044.x","article-title":"A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua prediction score","volume":"8","author":"Barbar","year":"2010","journal-title":"J Thromb Haemost"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"104867","DOI":"10.1016\/j.ijnurstu.2024.104867","article-title":"External validation of the Khorana score for the prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis","volume":"159","author":"Huang","year":"2024","journal-title":"Int J Nurs Stud"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1681072","DOI":"10.3389\/fimmu.2025.1681072","article-title":"Integrating deep learning features from mammography with SHAP values for a machine learning model predicting over 5-year recurrence of breast ductal carcinoma in situ post-lumpectomy","volume":"16","author":"Sha","year":"2025","journal-title":"Front Immunol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2541316","DOI":"10.1080\/07853890.2025.2541316","article-title":"Machine learning and SHAP value interpretation for predicting the response to neoadjuvant chemotherapy and long-term clinical outcomes in Chinese female breast Cancer","volume":"57","author":"Yuan","year":"2025","journal-title":"Ann Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s10462-025-11399-0","article-title":"Interpretable and explainable machine learning methods for predictive process monitoring: a systematic literature review","volume":"58","author":"Mehdiyev","year":"2025","journal-title":"Artif Intell Rev"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/0002-9378(90)91007-Y","article-title":"Preoperative assessment of fragment D-dimer as a predictor of postoperative venous thrombosis","volume":"162","author":"Olt","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1136\/ijgc-2019-000914","article-title":"Deep vein thrombosis and serum D-dimer after pelvic lymphadenectomy in gynecological cancer","volume":"30","author":"Komatsu","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/s41416-018-0269-5","article-title":"D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis","volume":"119","author":"Jara-Palomares","year":"2018","journal-title":"Br J Cancer"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1111\/jth.14774","article-title":"Dynamic assessment of venous thromboembolism risk in patients with cancer by longitudinal D-dimer analysis: a prospective study","volume":"18","author":"Posch","year":"2020","journal-title":"J Thromb Haemost"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1111\/j.1538-7836.2012.04913.x","article-title":"Anticoagulants in cancer","volume":"10","author":"Siegal","year":"2012","journal-title":"J Thromb Haemost"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1200\/JCO.2011.40.1810","article-title":"Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and thrombosis study","volume":"30","author":"Ahlbrecht","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.cllc.2024.04.004","article-title":"Risk of venous thromboembolism in patients with stage III and IV non-small-cell lung cancer: nationwide descriptive cohort study","volume":"25","author":"Ording","year":"2024","journal-title":"Clin Lung Cancer"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.medj.2021.02.002","article-title":"Increased incidence of venous thromboembolism with cancer immunotherapy","volume":"2","author":"Roopkumar","year":"2021","journal-title":"Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1001\/jamainternmed.2023.8232","article-title":"Complication rates of central venous catheters","volume":"184","author":"Teja","year":"2024","journal-title":"JAMA Intern Med"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e1091","DOI":"10.1634\/theoncologist.2019-0676","article-title":"Fundamental research in oncology and thrombosis 2 (FRONTLINE 2): a follow-up survey","volume":"25","author":"Kakkar","year":"2020","journal-title":"Oncologist"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1076029620913942","DOI":"10.1177\/1076029620913942","article-title":"Can intermittent pneumatic compression reduce the incidence of venous thrombosis in critically ill patients: a systematic review and meta-analysis","volume":"26","author":"Wang","year":"2020","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1056\/NEJMoa022157","article-title":"An association between atherosclerosis and venous thrombosis","volume":"348","author":"Prandoni","year":"2003","journal-title":"N Engl J Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.atherosclerosis.2005.03.047","article-title":"Coronary artery calcification and risk factors for atherosclerosis in patients with venous thromboembolism","volume":"183","author":"Hong","year":"2005","journal-title":"Atherosclerosis"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/jth.13329","article-title":"Impact of incident myocardial infarction on the risk of venous thromboembolism: the Troms\u00f8 study","volume":"14","author":"Rinde","year":"2016","journal-title":"J Thromb Haemost"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1365-2796.2007.01815.x","article-title":"Links between arterial and venous disease","volume":"262","author":"Prandoni","year":"2007","journal-title":"J Intern Med"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1161\/CIRCULATIONAHA.109.921460","article-title":"Risk factors for venous thromboembolism","volume":"121","author":"Holst","year":"2010","journal-title":"Circulation"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1161\/ATVBAHA.113.302162","article-title":"Carotid atherosclerosis predicts future myocardial infarction but not venous thromboembolism","volume":"34","author":"Hald","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1001\/jama.2020.17272","article-title":"Diagnosis and treatment of lower extremity venous thromboembolism","volume":"324","author":"Chopard","year":"2020","journal-title":"JAMA"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.1182\/blood-2008-08-175745","article-title":"Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival","volume":"113","author":"Ku","year":"2009","journal-title":"Blood"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1182\/blood.2019003603","article-title":"Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis","volume":"135","author":"Darzi","year":"2020","journal-title":"Blood"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s12149-014-0877-y","article-title":"Relationship between pretreatment levels of serum CYFRA 21-1, CEA and PET metabolic parameters in NSCLC","volume":"28","author":"Dogan","year":"2014","journal-title":"Ann Nucl Med"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1758835920952994","DOI":"10.1177\/1758835920952994","article-title":"CEA and CYFRA 21-1 as prognostic biomarkers and as a tool for treatment monitoring in advanced NSCLC treated with immune checkpoint inhibitors","volume":"12","author":"Dall\u2019Olio","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.canlet.2009.08.005","article-title":"P19ras represses proliferation of non-small cell lung cancer possibly through interaction with neuron-specific enolase (NSE)","volume":"289","author":"Jang","year":"2010","journal-title":"Cancer Lett"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ijrobp.2014.02.025","article-title":"Risk factors for brain metastases in locally advanced non-small cell lung cancer with definitive chest radiation","volume":"89","author":"Ji","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref48","first-page":"597","article-title":"Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer","volume":"6","author":"Bonner","year":"2000","journal-title":"Clin Cancer Res"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jtha.2023.02.029","article-title":"Cancer-associated thrombosis: enhanced awareness and pathophysiologic complexity","volume":"21","author":"Falanga","year":"2023","journal-title":"J Thromb Haemost"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-0-387-79962-9_3","article-title":"Activation of clotting factors in cancer","volume":"148","author":"Rickles","year":"2009","journal-title":"Cancer Treat Res"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.1200\/jco.2009.22.3271","article-title":"Assessing risk of venous thromboembolism in the patient with Cancer","volume":"27","author":"Khorana","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3324\/haematol.2012.073338","article-title":"Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and thrombosis study","volume":"98","author":"Dickmann","year":"2013","journal-title":"Haematologica"}],"updated-by":[{"DOI":"10.3389\/fmed.2026.1953862","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000}}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1853920\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:29:36Z","timestamp":1788863376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1853920\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":52,"alternative-id":["10.3389\/fmed.2026.1853920"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1853920","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"article-number":"1853920"}}